Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 8, 2021
- Revision received November 8, 2021
- Accepted November 10, 2021
- Published online November 30, 2021.
Copyright & Usage
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Author Information
- JOMNARONG LERTSUWAN1,
- ANYAPORN SAWASDICHAI2,
- NATHAPOL TASNAWIJITWONG3,
- KEVIN GASTON4,
- PADMA-SHEELA JAYARAMAN4,* and
- JUTAMAAD SATAYAVIVAD3,*⇑
- 1Laboratory of Immunology, Chulabhorn Research Institute, Bangkok, Thailand;
- 2Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok, Thailand;
- 3Laboratory of Pharmacology, Chulabhorn Research Institute, Bangkok, Thailand;
- 4Division of Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, U.K.
- Correspondence to: Associate Professor Jutamaad Satayavivad, Chulabhorn Research Institute, 54 Kamphaeng Phet 6, Talat Bang Khen, Lak Si, Bangkok 10210, Thailand. Tel: +66 25538555 ext. 8539 and 8540, e-mail: jutamaad{at}cri.or.th
In this issue
Sequence of CX-4945 and Cisplatin Administration Determines the Effectiveness of Drug Combination and Cellular Response in Cholangiocarcinoma Cells In Vitro
Jump to section
Related Articles
Cited By...
- No citing articles found.